VALIDATING USP27X AS A DRUG TARGET IN LUNG CANCER

$420,500FY2021Defense Health AgencyDOD

Health Research, Inc., Rockville MD

Investigators

View source on USAspending →

VALIDATING USP27X AS A DRUG TARGET IN LUNG CANCER · GrantIndex